Company intelligence / Profile preview

Canerix Formulations

Ahmedabad, Gujarat, India

Ownership: Private
Development stage: Other

Overview

Canerix Formulations is an Indian pharmaceutical company specializing in the development, manufacturing, and export of oncology medications. Based in Ahmedabad, the company focuses on providing high-quality generic anti-cancer drugs to global markets, including cytotoxic injections and oral solids. Their portfolio covers a wide range of therapeutic segments within oncology, aiming to make life-saving treatments more accessible and affordable. The company operates with a focus on international regulatory standards to ensure the efficacy and safety of its pharmaceutical products.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Canerix Formulations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canerix Formulations.

Explore the full profile